EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
24 05-2022

RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!


Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with [...]

25 04-2022

Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”


On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at [...]

23 03-2022

EBRA launches open consultation on Shared European Brain Research Agenda


The preparation of the Shared European Brain Research Agenda (SEBRA) is currently underway within the EBC-coordinated European Brain Research Area (EBRA) project, with the aim to provide recommendations on future areas for excellent, innovative, and translational research. Existing strategic research agendas have been taken into consideration and input has been collected from a first set of identified experts in the European brain research area. A Consultation is now [...]

22 03-2022

EBC celebrates 20 years!


Twenty years ago to this day, the European Brain Council (EBC) was formed. The brain child of Prof.  Jes Olesen, EBC was the answer to the need for increased unity within the brain community, building a more connected network of key players in the brain space — scientists, clinicians, patients, industry — encompassing basic [...]

18 03-2022

A look back at Brain Awareness Week 2022


Brain Awareness Week 2022 was a busy time period for EBC this year, with a series of virtual launches taking place, namely the release of the 2nd Round of the Value of Treatment project results and Calls to Action as well as the Save the Date for two major events later this year. On Monday, [...]

14 03-2022

Value of Treatment project releases results and calls to action on the occasion of Brain Awareness Week 2022


On the occasion of Brain Awareness Week 2022, the EBC-led Value of Treatment project – currently in its second round – releases results and calls to action this week. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project launched in 2015, with the objective to identify treatment [...]

9 02-2022

EBRA releases Mapping Report: investment in European brain research still vital


9 February 2022 The EU-funded European Brain Research Area project today releases its long-awaited European Research Inventory and Mapping Report, providing insight into the brain research activities funded at the European level within the EU framework programmes FP7 and Horizon 2020, as well as the funding initiatives of the EU Joint Programme – Neurodegenerative [...]

14 12-2021

Event report | Best practices for patient safety: An EU-wide view on the use of medicines off-label


On 30 November, the GOLUP consortium held a virtual event, led by the European Brain Council, to build on the latest discussions on the Declaration on Good Off-Label Use Practices.  The event was hosted by MEP Cyrus Engerer (S&D, Malta), who is a member of the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI). [...]

Go to Top